Reaccelerate on strong pipeline in FY23E
FY23有望延续高增长趋势,中长期业绩能见度提升
Gradual revenue and margin recovery in FY23
4Q22 beat; FY23E margins likely overestimated
FY23产品收入强劲,FY24重点关注泰它西普海外进展,维持买入评级
–Sequential margin contraction indicates inventory digestions may persist till FY23E
没有FY23E指导,但风险回报在那里
1H FY23收入符合预期
稳健的 FY23 具有更好的盈利能力